The Connecticut Bioscience Innovation Fund has awarded grants to two researchers studying a test for multiple sclerosis and a treatment for cancer, officials announced.
UConn Health Center’s Dr. Robert Clark will receive nearly $455,000 to further develop a blood-based test to diagnose multiple sclerosis. There is no single test on the market that can make a definite diagnosis, according to Connecticut Innovations, which manages the state-backed fund.
Meanwhile, Yale University’s Wu Dianqing has been awarded $500,000 to continue development of a target, antibody treatment for colorectal cancer — the third most common type of cancer in the developed world.
The CBIF has now awarded nearly $5 million since launching in early 2014.
